Subfertility Clinical Trial
Official title:
Evaluation of the Role of Follicular Sensitivity Index in the Prediction of ICSI/IVF Outcome in Women Without Polycystic Ovarian Syndrome
1000 women with infertility who are already decided to be treated with ICSI will be
subjected to full history taking and clinical examination. On the second day of menstruation
serum FSH, LH, Prolactin and Oestradiol will be assessed and the antral follicular count
(AFC) will be assessed using a vaginal ultrasound scan. AFC will be defined as the number of
follicles measuring 3-10mm.
All patients will have standard pituitary down-regulation followed by (Human menopausal
gonadotrophin (HMG) stimulation until the day of (Human chorionic gonadotrophin (HCG)
administration. On the day of HCG administration, ovarian ultrasound scan will be performed
using a transvaginal probe and the Preovulatory follicle count (PC) will be assessed, (PFC)
is defined as number of follicles measuring≥16mm. Follicular sensitivity index (FSI) will be
calculated as: (FSI =PFC*10000/AFC*Total dose of FSH)
Our study is observational, we are observing data from routine measurements during IVF/ICSI.
Our study does not assess IVF/ICSI as an intervention, we are evaluating the role of FSI
which is calculated by observing routine measurements during the IVF/ICSI procedure.
All women fulfilling the inclusion criteria will be invited to participate in the study. A
written informed consent will be taken and only women signing the consent will be included
in the study. Patients included in the study will be subjected to full history taking and
clinical examination including general, abdominal and gynecological examination. This will
be followed by a vaginal ultrasound scan to assess uterus, ovaries and any pelvic masses.
All women will go through the usual IVF/ICSI procedure explained below, our aim is to
observe the antral follicle count, the pre-ovulatory count, the total dose of FSH and
calculate the FSI then correlating this with pregnancy.
All patients will have standard pituitary down-regulation protocol with GnRHa (Triptorelin
0.1mg, Decapeptyl® Ferring, Germany) day 7 after ovulation of previous cycle or on day 21 of
the oral contraceptive cycles. GnRHa will be continued for 2 weeks. Human menopausal
gonadotrophin(HMG) (Merional ®IBSA) 150-300 IU/day will be administered until the day of HCG
administration.
On the day of HCG administration, ovarian ultrasound scan will be performed using a
transvaginal probe and the Preovulatory follicle count (PC) will be assessed, (PFC) is
defined as number of follicles measuring≥16mm. FSI will be calculated as: (FSI
=PFC*10000/AFC*Total dose of FSH) FSI values will be classified into 3 categories: low,
medium and high the 3 groups will be compared regarding the clinical pregnancy rate, number
of retrieved oocytes, number and quality of embryos The procedure will be cancelled if less
than 3 follicles 16-20 mm in size are present 12 days after starting FSH despite doses
reaching 450 IU. The cycle will be also cancelled if there is risk of ovarian
hyperstimulation like massive ovarian enlargement or serum estradiol exceeds 3000pg/L
Transvaginal oocyte retrieval will be performed 34-36 h after the administration of HCG.
Oocytes will be fertilized either via IVF or ICSI based on the couple's history.
Fertilization will be assessed 16-18 h after IVF or ICSI. Embryo transfers will be performed
3 days after oocyte retrieval. No more than three embryos per patient will be transferred;
vaginal tablets containing progesterone (Prontogest® IBSA) administered 400 mg/day as luteal
support from the day of the oocyte retrieval. Clinical pregnancy will be defined as
Visualization of an intrauterine gestational sac 5 weeks after embryo transfer.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03569787 -
Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire
|
||
| Completed |
NCT03105453 -
The Microbiome in Subfertility and Assisted Reproductive Technologies (ART)
|
||
| Terminated |
NCT02180256 -
Effect of Endometrial Scratching on Assisted Reproduction Outcomes: a Randomized Controlled Trial
|
N/A | |
| Terminated |
NCT02197832 -
A RCT on the Effect of Endometrial Injury on Improving Ongoing Pregnancy Rate in Subfertile Women Undergoing FET Cycles
|
N/A | |
| Completed |
NCT00971152 -
Effect of a Higher Than Maximum 450IU Gonadotropin Dose in an In-vitro Fertilization Cycle
|
Phase 3 | |
| Completed |
NCT01569945 -
Hormonal Stimulation in IUI Treatment: Is Clomifen Combined With Ethinyl Estradiol Better, Worse or Equal to Menopur
|
N/A | |
| Recruiting |
NCT04064840 -
GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET
|
Phase 3 | |
| Recruiting |
NCT02561793 -
DHEA Versus Placebo in Women With Poor Ovarian Response
|
Phase 3 | |
| Terminated |
NCT02570386 -
Clinical Effectiveness of Frozen Thawed Embryo Transfer Compared to Fresh Embryo Transfer
|
N/A | |
| Completed |
NCT02197208 -
A RCT Comparing Spontaneous Natural Cycles and Human Chorionic Gonadotrophin-induced Natural Cycles in FET
|
N/A | |
| Completed |
NCT01961336 -
Transdermal Testosterone Pretreatment in Poor Responders Undergoing IVF
|
Phase 3 | |
| Completed |
NCT02487940 -
Assessment of Intralipid Efficacy in Women With Unexplained Recurrent Implantation Failure
|
Phase 4 | |
| Completed |
NCT01385618 -
Gene-polymorphisms Relating to Human Subfertility
|
N/A | |
| Completed |
NCT00985062 -
Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization
|
N/A | |
| Recruiting |
NCT04538560 -
Preimplantation Genetic Testing for Aneuploidy of Polar Bodies
|
N/A | |
| Completed |
NCT02748278 -
Comparison of the Number of Oocytes Obtained Between Chinese and Caucasian Women in IVF Treatment
|
||
| Completed |
NCT02044445 -
Is the IVF Outcome Dependent on the Time Interval Between hCG Administration and Oocyte Retrieval?
|
N/A | |
| Completed |
NCT02863614 -
Analgesia for Endometrial Scratching
|
N/A | |
| Completed |
NCT02154958 -
Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility
|
N/A | |
| Completed |
NCT02151006 -
Does Dehydro Epiandrosterone (DHEA) Improve Pregnancy Rate in Women Undergoing IVF/ICSI With Expected Poor Ovarian Response?
|
Phase 3 |